C-Path

Filter by Category

All Annual Meetings Blog Events Newsletters Podcasts Posters Publications Webinars Workshops

Filter by Program

Filter by Date

March 19, 2021

C-Path Names COO Kristen Swingle Interim President

Joseph Scheeren departing the organization after two years of strong leadership TUCSON, Ariz., March 19, 2021 — Critical Path In

March 10, 2021

C-Path Program and Consortia Leaders Selected to Serve in Sr. Vice President and Vice President Roles

Inish O’Doherty and Sudhir Sivakumaran will lead new programs; Stephen Joel Coons and John-Michael Sauer move into Sr. VP roles.

December 3, 2020

C-Path, Ltd. Announces New Contract with Innovative Medicines Initiative

DUBLIN, Ireland, December 3, 2020 — Critical Path Institute, Ltd. (C-Path, Ltd.) announced today a new contract with the

November 5, 2020

Pediatric IBD Foundation, ImproveCareNow, C-Path to Establish the Children’s Registry for the Advancement of Therapeutics

TUCSON, Ariz., November 5, 2020 — The Pediatric IBD Foundation, ImproveCareNow, and the Critical Path Institute (C-Path)

April 30, 2020

C-Path Appoints Two New Members to Board of Directors

TUCSON, Ariz., April 30, 2020 — Tucson-based Critical Path Institute (C-Path) today announced the appointment of two new

April 21, 2020

C-Path Awarded FDA Contract to Enhance the Assessment of Clinical Outcomes in Pediatric Asthma Treatment Trials

Resulting novel drug development tools will support patient-focused drug development for children with asthma TUCSON

March 17, 2020

C-Path to Lead Multi-Stakeholder Engagement on FDA’s Proposed Novel Framework to Enhance the Pediatric Medical Device Ecosystem

TUCSON, Ariz., March 17, 2020 — The Critical Path Institute (C-Path) today announced it has been awarded a grant to condu

March 12, 2020

C-Path Appoints Dr. Klaus Romero as Chief Science Officer

TUCSON, Ariz., March 12, 2020 — The Critical Path Institute (C-Path) today announced the appointment of Klaus Rome

January 29, 2020

ERA4TB, an International Consortium to Accelerate the Development of Comprehensive Treatments Against Tuberculosis

C-Path, Ltd. and more than 30 partners from 13 countries participate in the ERA4TB project. The ERA4TB (European Regimen Ac

October 15, 2019

C-Path, CDISC Develop Standard to Represent Data for Animal Rule Studies

TUCSON, Ariz. and AUSTIN, Texas, October 15, 2019 — The Critical Path Institute (C-Path) and CDISC are pleased to announc

Previous34 5...7 Next